Envoy Medical (COCH) EPS (Weighted Average and Diluted) (2022 - 2025)
Historic EPS (Weighted Average and Diluted) for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to -$0.35.
- Envoy Medical's EPS (Weighted Average and Diluted) rose 1025.64% to -$0.35 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.36, marking a year-over-year decrease of 1623.93%. This contributed to the annual value of -$1.49 for FY2024, which is 4146.46% up from last year.
- According to the latest figures from Q3 2025, Envoy Medical's EPS (Weighted Average and Diluted) is -$0.35, which was up 1025.64% from -$0.32 recorded in Q2 2025.
- Over the past 5 years, Envoy Medical's EPS (Weighted Average and Diluted) peaked at $0.23 during Q1 2022, and registered a low of -$1.31 during Q1 2023.
- Moreover, its 4-year median value for EPS (Weighted Average and Diluted) was -$0.35 (2025), whereas its average is -$0.43.
- Over the last 5 years, Envoy Medical's EPS (Weighted Average and Diluted) had its largest YoY gain of 20000.0% in 2023, and its largest YoY loss of 228093.26% in 2023.
- Quarter analysis of 4 years shows Envoy Medical's EPS (Weighted Average and Diluted) stood at -$1.13 in 2022, then surged by 55.0% to -$0.51 in 2023, then grew by 19.54% to -$0.41 in 2024, then rose by 14.73% to -$0.35 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.35 in Q3 2025, compared to -$0.32 in Q2 2025 and -$0.29 in Q1 2025.